Metastasis Directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-Resistant Prostate Cancer

被引：0

作者：

Deek, M. P. ^{[1
]}

Taparra, K. ^{[2
]}

Phillips, R. ^{[1
]}

Velho, P. Isaacsson ^{[1
]}

Gao, R. W. ^{[3
]}

Deville, C., Jr. ^{[1
]}

Song, D. ^{[4
]}

Greco, S. C. ^{[4
]}

Carducci, M. ^{[1
]}

Eisenberger, M. ^{[1
]}

DeWeese, T. L. ^{[4
]}

Denmeade, S. ^{[1
]}

Pienta, K. ^{[5
]}

Paller, C. ^{[1
]}

Antonarakis, E. S. ^{[1
]}

Olivier, K. ^{[6
]}

Park, S. S. ^{[6
]}

Tran, P. T. ^{[4
]}

Stish, B. J. ^{[6
]}

机构：

[1] Johns Hopkins Med, Baltimore, MD USA

[2] Mayo Clin, Alix Sch Med, Rochester, MN USA

[3] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA

[4] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA

[5] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Med Oncol, Baltimore, MD USA

[6] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4079

引用

页码：E893 / E894

页数：2

共 50 条

[11] Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer
Galletti, Giuseppe
Leach, Benjamin I.
Lam, Linda
Tagawa, Scott T.
CANCER TREATMENT REVIEWS, 2017, 57 : 16 - 27
[12] Pathophysiology and therapy of castration-resistant prostate cancer
Merseburger, A. S.
Kuczyk, M. A.
Wolff, J. M.
UROLOGE, 2013, 52 (02): : 219 - 225
[13] Satraplatin for the therapy of castration-resistant prostate cancer
Sonpavde, Guru
Sternberg, Cora N.
FUTURE ONCOLOGY, 2009, 5 (07) : 931 - 940
[14] Radioisotope Imaging and Therapy for Bone Metastasis in Men With Castration-Resistant Prostate Cancer
Swami, Umang
Yap, Jeffrey T.
Agarwal, Neeraj
JAMA ONCOLOGY, 2020, 6 (02) : 225 - 226
[15] Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients' selection
Franzese, Ciro
Perrino, Matteo
Marzo, Marco Antonio
Badalamenti, Marco
Baldaccini, Davide
D'Agostino, Giuseppe
Marini, Beatrice
De Vincenzo, Fabio
Zucali, Paolo Andrea
Scorsetti, Marta
CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (03) : 449 - 457
[16] Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients’ selection
Ciro Franzese
Matteo Perrino
Marco Antonio Marzo
Marco Badalamenti
Davide Baldaccini
Giuseppe D’Agostino
Beatrice Marini
Fabio De Vincenzo
Paolo Andrea Zucali
Marta Scorsetti
Clinical & Experimental Metastasis, 2022, 39 : 449 - 457
[17] Palliative systemic therapy of castration-resistant prostate cancer. Current developments
Finter, F.
Rinnab, L.
Gust, K.
Kuefer, R.
UROLOGE, 2009, 48 (11): : 1295 - 1301
[18] Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: A Systematic Review
Loblaw, D. A.
Walker-Dilks, C.
Winquist, E.
Hotte, S. J.
CLINICAL ONCOLOGY, 2013, 25 (07) : 406 - 430
[19] Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
Katano, Atsuto
Yamashita, Hideomi
Nakagawa, Keiichi
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
[20] Secondary Hormone Therapy for Castration-Resistant Prostate Cancer
Taplin, Mary-Ellen
ONCOLOGY-NEW YORK, 2013, 27 (05): : 371 - +

← 1 2 3 4 5 →